Works by Tashima, Toshihiko

Results: 13

Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates.

Published in:

Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071597

By:

Tashima, Toshihiko

Publication type:

Article

Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport.

Published in:

2025

By:

Tashima, Toshihiko

Publication type:

Literature Review

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood–Brain Barrier.

Published in:

Pharmaceutics, 2024, v. 16, n. 3, p. 361, doi. 10.3390/pharmaceutics16030361

By:

Tashima, Toshihiko;
Tournier, Nicolas

Publication type:

Article

Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood–Brain Barrier.

Published in:

Pharmaceutics, 2024, v. 16, n. 2, p. 289, doi. 10.3390/pharmaceutics16020289

By:

Tashima, Toshihiko

Publication type:

Article

Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.

Published in:

Pharmaceutics, 2022, v. 14, n. 2, p. 411, doi. 10.3390/pharmaceutics14020411

By:

Tashima, Toshihiko

Publication type:

Article

Delivery of Orally Administered Digestible Antibodies Using Nanoparticles.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3349, doi. 10.3390/ijms22073349

By:

Tashima, Toshihiko;
Spallarossa, Andrea

Publication type:

Article

Substance Delivery across the Blood-Brain Barrier or the Blood-Retinal Barrier Using Organic Cation Transporter Novel Type 2 (OCTN2).

Published in:

Future Pharmacology, 2024, v. 4, n. 3, p. 479, doi. 10.3390/futurepharmacol4030027

By:

Tashima, Toshihiko

Publication type:

Article

Ocular Drug Delivery into the Eyes Using Drug-Releasing Soft Contact Lens.

Published in:

Future Pharmacology, 2024, v. 4, n. 2, p. 336, doi. 10.3390/futurepharmacol4020019

By:

Tashima, Toshihiko

Publication type:

Article

Carrier-Mediated Delivery of Low-Molecular-Weight N -Containing Drugs across the Blood–Brain Barrier or the Blood–Retinal Barrier Using the Proton-Coupled Organic Cation Antiporter.

Published in:

Future Pharmacology, 2023, v. 3, n. 4, p. 742, doi. 10.3390/futurepharmacol3040046

By:

Tashima, Toshihiko

Publication type:

Article

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier.

Published in:

Antibodies (2073-4468), 2023, v. 12, n. 3, p. 43, doi. 10.3390/antib12030043

By:

Tashima, Toshihiko

Publication type:

Article

Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect.

Published in:

Antibodies (2073-4468), 2022, v. 11, n. 4, p. 78, doi. 10.3390/antib11040078

By:

Tashima, Toshihiko

Publication type:

Article

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin.

Published in:

Molecules, 2020, v. 25, n. 21, p. 5188, doi. 10.3390/molecules25215188

By:

Tashima, Toshihiko;
Grumezescu, Alexandru Mihai

Publication type:

Article

A role for fragment-based drug design in developing novel lead compounds for central nervous system targets.

Published in:

Frontiers in Neurology, 2015, p. 1, doi. 10.3389/fneur.2015.00197

By:

Wasko, Michael J.;
Pellegrene, Kendy A.;
Madura, Jeffry D.;
Surratt, Christopher K.;
Khoshbouei, Habibeh;
Toshihiko Tashima

Publication type:

Article